The device, which is shaped to mimic the natural geometry of human vasculature, compared favorably with drug-coated balloons and stents.
Veryan Medica‘s helical BioMimics 3D stent met its primary safety and efficacy endpoints in a study of 271 patients with symptomatic femoropopliteal artery disease, according to TCTMD.
The device, which is shaped to mimic the natural geometry of human vasculature, compared favorably with drug-coated balloons and stents.
The probability of maintaining primary patency after 12 months was 81.9% for the BioMimics 3D device.
